Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan

Immunotherapy, Ahead of Print.

Source: Immunotherapy - September 20, 2023 Category: Allergy & Immunology Authors: Yoshitaka Okamoto Moe Kato Kiyonori Ishii Yumi Sato Tomohisa Hata Yuta Asaka Source Type: research